117,431 research outputs found
Myocardial infarction and diabetes mellitus : studies on glucose lowering therapies and novel risk markers based on observations from the DIGAMI 2 trial
No full textBackground: Patients with myocardial infarction (MI) and type 2 diabetes (T2DM) and have a poor prognosis. Hyperglycemia is an independent risk predictor. The best tools for glucose control are debated. Important is identification of biomarkers to gain further pathophysiological insights and new therapeutic possibilities.Aims: In patients with acute MI and T2DM: 1. Explore the prognostic impact of hypoglycemia during hospitalization for MI; 2. Study the prognostic impact of glucose lowering treatment; 3. Investigate the relation between Copeptin and IGFBP-1 and their prognostic impact; and 4. Characterize MBL geno- and phenotypes and to investigate their prognostic importance.Study population: This thesis is based on epidemiological reports from the DIGAMI 2 trial comprising 1253 patients with T2DM and acute MI. DIGAMI 2 was a randomized trial with the primary aim to compare three glucose lowering strategies testing the hypothesis that insulin-based metabolic control reduces mortality.Hypoglycemia during hospitalization for acute MI: Hypoglycemic episodes were recorded in 153 patients (symptomatic = 45). Patients with hypoglycemia were older, had a longer duration of T2DM, a lower body weight and more often a history of heart failure. The mortality and cardiovascular morbidity did not differ between patients with or without hypoglycemia besides that patients who were symptomatic were at increased risk of death. This higher risk disappeared after adjustment for confounding factors.Glucose lowering treatment and prognosis: During the initial follow-up of 2.3 years the adjusted hazard ratio (HR) for non-fatal MI and stroke, in patients discharged alive (n=1181), was 1.73 (95% CI 1.26 2.37; p =0.0007) with insulin treatment, 0.81 (95% CI 0.57 1.14; p = 0.23) with sulphonylureas and 0.63 (95% CI 0.42 0.95; p = 0.03) with metformin. None of the glucose lowering treatments influenced mortality. The odds ratio for insulin on non-fatal cardiovascular events was 1.90 (95% CI 1.38-2.63; p=Novel risk markers and prognosis: Copeptin, a surrogate marker for vasopressin, was associated with IGFBP-1 (r = 0.53; pConclusions: Hypoglycemia during hospitalization is not an independent risk factor for mortality and cardiovascular morbidity in patients with T2DM and MI. It is more prevalent in patient at high risk for other reasons. Glucose lowering agents seem to impact cardiovascular morbidity, mortality and deaths from malignancies, a finding that deserves further evaluation. Copeptin may explain at least some of the prognostic impact ofIGFBP-1 in these patients an observation that may open for new therapeutic attempts. MBL did not have a significant impact on prognosis.List of scientific papersI. Mellbin LG, Malmberg K, Waldenström A, Wedel H, Rydén L; DIGAMI 2 investigators (2009). "Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial." Heart 95(9): 721-7. Epub 2008 Nov 24 https://pubmed.ncbi.nlm.nih.gov/19029171II. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators (2008). "The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial." Eur Heart J 29(2): 166-76. Epub 2007 Dec 21 https://pubmed.ncbi.nlm.nih.gov/18156614III. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L (2010). "Insulin in patients with acute myocardial infarction and diabetes friend or foe A report from the DIGAMI 2 study" (Submitted)IV. Mellbin LG, Rydén L, Brismar K, Morgenthaler NG, Ohrvik J, Catrina SB (2010). "C-terminal-ProVasopressin (Copeptin), IGFBP-1 and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: A report from the DIGAMI 2 trial." Diabetes Care Apr 22: Epub ahead of print https://pubmed.ncbi.nlm.nih.gov/20413521V. Mellbin LG, Hamsten A, Malmberg K, Steffensen R, Rydén L, Öhrvik J, Hansen TK (2010). "Mannose-binding lectin genotype and phenotype and their impact on cardiovascular prognosis in patients with type 2 diabetes and myocardial infarction A report from the DIGAMI 2 trial" (Submitted)</p
Going Beyond Counting First Authors in Author Co-citation Analysis
No full textThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Square Dancing with the Stars to Enhance Dynamic Hirschman Linkages?
No full textIn this Presidential Address, the author takes the reader on a reconnaissance of his life and time as a regional scientist. He points out scenery he found scintillating along the way, hoping that some may pick up the banner and chew on a few of the ideas for a while. He suggests a revisit to Albert O. Hirschman’s notion of key sectors and more empirical analysis related to Marcus Berliant’s and Masahisa Fujita’s notion of knowledge creation and transfer.Presidential Address, San Antonio, Texas, March 29, 2014 (53rd Meetings of the Southern Regional Science Association
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Letter from unknown writer to Jesse L. Boyce
No full textLetter to Jesse L. Boyce from unknown author (possibly Jack) about the investigation into the powder magazine located in the Grand Canyon. Some personal news is included in the letter such as the writer's marriage to the daughter of C.A. Taylor, former Supervisor of Cochise County
Dispelling the Myths Behind First-author Citation Counts
No full textWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Sarah L. Blum Author Visit - Warrior Nurse: PTSD and Healing
No full textHear Sarah L. Blum, author of Women Under Fire: Abuse in the Military, discuss her newest book, Warrior Nurse: PTSD and Healing followed by a Q&A and book signing.
Sarah L. Blum is a decorated Vietnam veteran who served as an operating room nurse during the intense fighting of 1967. In recognition of her service, she was awarded the Army Commendation Medal.
Sponsored by CWU Veterans Center and CWU Libraries.https://digitalcommons.cwu.edu/libraryevents/1252/thumbnail.jp
Lillian L. Lambert, Author, Speaker, and Entrepreneur
No full textLillian L. Lambert, Author, Speaker, and Entrepreneu
Letter to Alfred L. Shoemaker, February 10, 1948
No full textA handwritten letter from an unknown author addressed to Alfred L. Shoemaker, dated February 10, 1948. Within, the author discusses the Pennsylvania Dutch word for Ash Wednesday, along with traditions associated with this day.https://digitalcommons.ursinus.edu/shoemaker_documents/1118/thumbnail.jp
- …
